Results for tag: "Tenecteplase"

Tenecteplase is a type of cardiovascular drug used to treat acute myocardial infarction (AMI). It is a recombinant form of tissue plasminogen activator (tPA), a naturally occurring enzyme that helps dissolve blood clots. Tenecteplase is administered intravenously and works by breaking down the clot and restoring blood flow to the heart. It is used in combination with other medications to reduce the risk of death and complications from AMI. Tenecteplase is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2000. It is used in many countries around the world, including the United States, Canada, Europe, and Japan. It is generally considered to be a safe and effective treatment for AMI, with few side effects. The Tenecteplase market is highly competitive, with several major pharmaceutical companies offering the drug. These include Sanofi, Pfizer, Bristol-Myers Squibb, and Boehringer Ingelheim. Other companies, such as Merck, Novartis, and AstraZeneca, also offer Tenecteplase in some countries. Show Less Read more